These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 1669174)

  • 1. [Comparison of thiamazole pharmacokinetics in healthy individuals and patients with hyperthyroidism].
    Syrenicz A; Gawrońska-Szklarz B; Wójcicki J; Czekalski S
    Pol Tyg Lek; 1991 Oct 28-Nov 4; 46(43-44):838-40. PubMed ID: 1669174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic parameters of thiamazole in hyperthyroid patients responding rapidly and slowly to the treatment.
    Syrenicz A; Gawrońska-Szklarz B; Wójcicki J; Czekalski S
    Pol J Pharmacol Pharm; 1991; 43(3):207-12. PubMed ID: 1961693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum thyroxine and triiodothyronine levels after a single dose and after 2-month-long thiamazole treatment of Graves' disease with reference to drug's pharmacokinetics].
    Syrenicz A
    Ann Acad Med Stetin; 1990; 36():133-52. PubMed ID: 2099104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acetylation phenotype in Graves' disease].
    Górnik W; Syrenicz A; Gawrońska-Szklarz B; Wójcicki J
    Pol Tyg Lek; 1989 Aug 7-14; 44(32-33):743-5. PubMed ID: 2641798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of antioxidative enzymes and concentration of malondialdehyde as oxidative status markers in women with newly diagnosed Graves-Basedow disease and after thiamazole therapy leading to euthyroidism.
    Rybus-Kalinowska B; Zwirska-Korczala K; Kalinowski M; Kukla M; Birkner E; Jochem J
    Pol Arch Med Wewn; 2008; 118(7-8):420-5. PubMed ID: 18714737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of phenazone in patients with fast and slow euthyroidism after methimazole treatment].
    Wójcicki J; Górnik W; Syrenicz A; Gawrońska-Szklarz B; Czekalski S
    Pol Tyg Lek; 1990 Feb 5-12; 45(6-7):131-3. PubMed ID: 2216952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment.
    Amato G; Mazziotti G; Sorvillo F; Piscopo M; Lalli E; Biondi B; Iorio S; Molinari A; Giustina A; Carella C
    Bone; 2004 Sep; 35(3):785-91. PubMed ID: 15336617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of disorders of thyroid function on phenazone pharmacokinetics].
    Bolanowski M; Orzechowska-Juzwenko K; Gruszka S; Szymczak J
    Pol Tyg Lek; 1990 Feb 5-12; 45(6-7):136-9. PubMed ID: 2216953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress peripheral parameters in Graves' disease: the effect of methimazole treatment in patients with and without infiltrative ophthalmopathy.
    Bednarek J; Wysocki H; Sowiński J
    Clin Biochem; 2005 Jan; 38(1):13-8. PubMed ID: 15607311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methimazole protection against oxidative stress induced by hyperthyroidism in Graves disease.
    Sewerynek J; Wiktorska J; Nowak D; Lewinski A
    Endocr Regul; 2000 Jun; 34(2):83-9. PubMed ID: 10911409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of methimazole in normal subjects and hyperthyroid patients.
    Okamura Y; Shigemasa C; Tatsuhara T
    Endocrinol Jpn; 1986 Oct; 33(5):605-15. PubMed ID: 3830069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
    Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Barani L; Ferrannini E; Serio M
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):189-95. PubMed ID: 16430719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose.
    Perozim LM; Lima N; Knobel M; Cavaliere H; Medeiros-Neto G
    Eur J Med; 1993 Feb; 2(2):70-4. PubMed ID: 8258020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidants and methimazole in the treatment of Graves' disease: effect on urinary malondialdehyde levels.
    Guerra LN; Ríos de Molina Mdel C; Miler EA; Moiguer S; Karner M; Burdman JA
    Clin Chim Acta; 2005 Feb; 352(1-2):115-20. PubMed ID: 15653105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of gender and phase of the menstrual cycle on the kinetics of ranitidine in healthy volunteers.
    Flores Pérez J; Juárez Olguín H; Flores Pérez C; Pérez Guillé G; Guillé Pérez A; Camacho Vieyra A; Toledo López A; Carrasco Portugal M; Lares Asseff I
    Chronobiol Int; 2003 May; 20(3):485-94. PubMed ID: 12868543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of hepatic metabolism affecting pharmacokinetics of propranolol in humans.
    Kiriyama A; Honbo A; Iga K
    Int J Pharm; 2008 Feb; 349(1-2):53-60. PubMed ID: 17765415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of different thyroid status on the pharmacokinetics of diazepam].
    Xu F; Zhang Y; Lou Y
    Yao Xue Xue Bao; 1998 Aug; 33(8):571-5. PubMed ID: 12016895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.